These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3661209)

  • 1. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical analysis of the USP 18 content uniformity sampling plan for tablets.
    Langenbucher F
    Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143
    [No Abstract]   [Full Text] [Related]  

  • 3. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical characteristics of the USP content uniformity test.
    Pedersen AO; Torud Y
    Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissolution test acceptance sampling plans.
    Tsong Y; Hammerstrom T; Lin K; Ong TE
    J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: USP content uniformity test.
    Madan PL
    J Pharm Sci; 1976 Jan; 65(1):VIII. PubMed ID: 1255410
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a market surveillance study in The Netherlands on break-mark tablets.
    Barends DM; Groot DW; van der Steen JC; de Kaste D; Frijlink HW
    Pharmeur Sci Notes; 2006 Dec; 2006(2):1-7. PubMed ID: 17691208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The USP content uniformity test. Analysis and proposals.
    Setnikar I
    Pharm Acta Helv; 1974; 49(9-10):302-8. PubMed ID: 4462139
    [No Abstract]   [Full Text] [Related]  

  • 9. Some properties of the USP content-uniformity test as related to control charts and validation of solid dosage forms.
    Bolton S
    J Pharm Sci; 1985 May; 74(5):572-4. PubMed ID: 4020637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric two-stage sequential quality assurance test of dose content uniformity.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(1):143-57. PubMed ID: 17219760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of statistical analysis of blend and dosage unit content uniformity data obtained from the Product Quality Research Institute Blend Uniformity Working Group data-mining effort.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Geoffroy JM; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N; Whiteman D;
    PDA J Pharm Sci Technol; 2004; 58(2):62-74. PubMed ID: 15113072
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of prednisone tablets submitted by U.S. hospitals.
    Juhl YH
    Am J Hosp Pharm; 1986 Jan; 43(1):98-102. PubMed ID: 3953589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uniformity of content requirements for tablets and capsules.
    Kendall CE; Low GK; Hailey DM
    J Pharm Pharmacol; 1981 Apr; 33(4):197-202. PubMed ID: 6115899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the analytical error on content uniformity sampling plans.
    Norberg R
    Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on a new sampling scheme by variables for the content uniformity of tablets].
    Zhong DF; Wang X; Luo X
    Yao Xue Xue Bao; 1986 Feb; 21(2):130-6. PubMed ID: 3751592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measurement and quality control of dosage forms. XIX. Weibull's statistical distribution and its use in the study of mechanical strength of tablets].
    Zácek H; Muzík M
    Cesk Farm; 1981 Jun; 30(5):150-5. PubMed ID: 7296683
    [No Abstract]   [Full Text] [Related]  

  • 17. Discriminatory power of the different requirements for uniformity of dosage units in the European pharmacopoeia.
    Limberg J; Savsek M
    Pharmeur Sci Notes; 2006 Dec; 2006(2):45-8. PubMed ID: 17691214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the correction of systematic errors of analytical methods used in the content uniformity test].
    Guo XJ; He CF; Luo X; Wang X
    Yao Xue Xue Bao; 1992; 27(9):695-700. PubMed ID: 1293943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.